Blueshift Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$45.8 - $85.4 $198,268 - $369,696
-4,329 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$62.2 - $84.4 $269,263 - $365,367
4,329 New
4,329 $314,000
Q3 2021

Nov 12, 2021
SELL
$77.92 - $102.4 $293,524 - $385,740
-3,767 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$92.19 - $115.71 $347,279 - $435,879
3,767 New
3,767 $359,000

Others Institutions Holding RARE

# of Institutions
324
Shares Held
85.6M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.95B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email